NUVELO INC 13G

Company

Oruka Therapeutics, Inc.

Filed

January 12, 2007

Accession Number

0000908733-07-000215

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →